Kyowa Kirin

Healthcare & Medicine

Kyowa Kirin

Kyowa_Kirin_Logo_2019.svg

600×97 · 3.89 KB

Download SVG

Kyowa_Kirin_Logo_2019.png

10240×1666 · 323 KB

Kyowa_Kirin_Logo_2008.svg

1477×139 · 6.49 KB

Download SVG

Kyowa_Kirin_Logo_2008.png

10240×964 · 262 KB

Kyowa_Hakko_Kogyo_Logo_1981.svg

881×711 · 4.58 KB

Download SVG

Kyowa_Hakko_Kogyo_Logo_1981.png

10240×8262 · 936 KB

Kyowa_Hakko_Kogyo_Logo_1981_3D.png

1000×814 · 338 KB

About the brand ❤️

Kyowa Kirin is a Japanese multinational biopharmaceutical company established in 1949 and headquartered in Tokyo, Japan. It specialises in the research, development, manufacturing and commercialisation of innovative prescription medicines. Its main therapeutic areas include rare diseases, oncology, haematology, bone and mineral disorders, and immunology. The company is particularly recognised for its expertise in biotechnology, antibody engineering and advanced therapeutic research. As a member of the Kirin Holdings Group, Kyowa Kirin operates internationally, collaborating with healthcare professionals, research institutions and pharmaceutical partners to develop treatments for patients with serious and underserved medical conditions.

Founded: 1949

Headquarters: Otemachi Financial City Grand Cube, 1-9-2 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan

Owner: Kirin Holdings Company, Limited (Japanese corporate group and parent company of Kyowa Kirin)

https://www.kyowakirin.com/